A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
Clinical trial NCT07420257 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07420257
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2028-10-30
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.